Sujal Shah - Chief Executive Officer, Cymabay Therapeutics, Inc

As of January 28, 2021


Sujal Shah Net Worth

  • Net worth is estimated to be at least $462K
  • Owns at least 120,000 units of Cymabay Therapeutics, Inc stock

Sujal Shah Trading

  • Largest purchase of shares was 55,000 units , worth over $76.45K on April 6, 2016
  • In total has made about 20 transactions over 6 years
  • Usually trades in January, with the busiest year in 2017
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Sujal Shah Mailing Address

  • Mailing address is C/o Cymabay Therapeutics, Inc. 7575 Gateway Blvd., Suite 110 Newark CA 94560 CA

Cymabay Therapeutics, Inc Insider Trading

  • The most recent transaction was 5,000 units bought on October 15, 2019 by Sujal Shah worth over $21.5K
  • In the last 4 years, insiders at Cymabay Therapeutics, Inc sold an estimated value of $18.17M and bought an estimated value of $6.62M
  • The most active traders are Kurt von Emster, Director,  Sujal Shah, Chief Executive Officer,  and Charles McWherter, Chief Scientific Officer
  • Insider trading is most common in January, with the busiest year in 2017

CymaBay Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1